6/30/2025CDE Reopens Public Consultation on Revised Technical Guidelines for Co...

6/20/2025CDE Solicits Comments on the Draft ICH Guideline E21: Inclusion of Pr...

6/20/2025CDE Solicits Comments on the Draft ICH Guideline E21: Inclusion of P...

6/20/2025CDE Issues the Technical Guidelines for IVRT and IVPT of Locally Actin...

6/19/2025CDE Solicits Comments on the Application Dossier Requirements for Clin...

6/19/2025CDE Solicits Comments on the Draft Technical Guidelines for Clinical R...

6/16/2025NMPA Seeks Comments on Initiative to Optimize Clinical Trial Review Pr...

6/10/2025CDE Seeks Comments on Draft Guidelines for Defining and Classifying Ad...

6/10/2025CDE Seeks Public Feedback on Second Batch of 2025 External Expert Addi...

6/9/2025CDE Solicits Comments on Draft Guidance on Post-Approval Change Manage...

5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...

5/29/2025CDE Issues Guideline on Production Site Change Research for Licensed B...

5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...

5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...

5/22/2025CDE Issues the Guideline on Clinical Trials for Alzheimer's Disease Dr...

5/20/2025CDE Seeks Feedback on Draft Guidelines for Designing Clinical Trials I...

5/20/2025CDE Solicits Feedback on Draft Guidelines for Writing Elderly Patient ...

5/20/2025CDE Seeks Comments on Draft Guideline for Age-Friendly Design in Innov...

5/20/2025CDE Solicits Comments on the 94th Batch of Reference Formulations for ...

5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...

5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...

5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...

5/7/2025CDE Seeks Comments on Draft Guidelines for Subject Selection in Bioequ...

5/7/2025CDE Publicizes the List of Reference Formulations for Generic Chemical...

5/6/2025China Seeks Feedbacks on Draft Guideline for Risk Management Plan Duri...

5/6/2025China Seeks Feedbacks on ICH Q1 Stability Testing Guideline Draft

5/6/2025China Announces Ambitious Plan to Optimize Primary Healthcare System b...

4/29/2025China NMPA Suspends Digoxin API Imports from VITAL LABS

Page:1/7 Total number of articles:202: [First][<<] [1] [2] [3] [4] [5] [>>] [End]